Episode Details
Back to Episodes
Boston Scientific, Hewlett Packard: Winners; Bristol-Myers: Loser
Description
Bristol-Myers Squibb stagnates, while Boston Scientific and Hewlett Packard Enterprise surge. The pharmaceutical giant faces flat sales and declining earnings, but medical device maker Boston Scientific boasts impressive growth and profitability. Tech titan Hewlett Packard Enterprise, with steady contracts and projected revenue growth, is another promising investment. Avoid Bristol-Myers Squibb, but consider Boston Scientific and Hewlett Packard Enterprise for robust growth and profitability.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/de9093a58f75c78b